Avalo Therapeutics (AVTX) Quick Ratio: History & Chart

Avalo Therapeutics, Inc.(AVTX)

Biotechnology · Wayne, PA

$13.69-0.91 (-6.23%)

Delayed quote: Oct 6, 2026, 10:10 AM EDT

About Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc. is a precision medicine company in the clinical development phase, dedicated to identifying, advancing, and marketing specialized treatments for patients experiencing critical unmet medical needs across the fields of immunology, immuno-oncology, and rare genetic disorders. Among its key pipeline assets is AVTX-002, a fully human monoclonal antibody designed to inhibit LIGHT. This drug is currently undergoing Phase II clinical trials for non-eosinophilic asthma and inflammatory bowel diseases, specifically moderate to severe Crohn's disease and ulcerative colitis. Furthermore, AVTX-002 is also being investigated in Phase III for its potential to treat acute respiratory distress syndrome caused by COVID-19. The company is also advancing AVTX-007, a fully human monoclonal antibody targeting IL-18, which is progressing through Phase I clinical studies for Still's disease, encompassing both adult-onset Still's disease and systemic juvenile idiopathic arthritis. Avalo's late-stage pipeline includes two products addressing rare genetic conditions, both in Phase III clinical trials: AVTX-801, a D-galactose substrate replacement therapy for phosphoglucomutase 1 deficiency (PGM1), also known as PGM1-CDG; and AVTX-803, an L-fucose substrate replacement therapy intended for LADII, medically referred to as SLC35C1-CDG. Established in 2011, the corporation initially operated as Cerecor Inc. before rebranding as Avalo Therapeutics, Inc. in August 2021. Its main operations are situated in Rockville, Maryland.

Wayne, PA

33 employees

www.avalotx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Garry A. Neil

View full financials

AVTX Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

19.31

QUICK RATIO (ACID-TEST) AVG TTM

12.36

QUICK RATIO (ACID-TEST) AVG 3Y

8.58

QUICK RATIO (ACID-TEST) AVG 5Y

3.62

QUICK RATIO (ACID-TEST) AVG 10Y

1.63

QUICK RATIO (ACID-TEST) AVG 15Y

N/A

QUICK RATIO (ACID-TEST) AVG 20Y

N/A

CURRENT VS TTM AVG

+56.14%

CURRENT VS 3Y AVG

+124.94%

CURRENT VS 5Y AVG

+433.85%

CURRENT VS 10Y AVG

+1083.85%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

2.99

median of 565 covered companies

CURRENT VS SECTOR MEDIAN

+545.68%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
Avalo Therapeutics, Inc. (AVTX)	$719.62M	19.31	12.36	8.58	3.62
Anteris Technologies Global Corp. (AVR)vs ›	$716.11M	14.20	2.59	2.42	2.06
Collegium Pharmaceutical, Inc. (COLL)vs ›	$718.41M	0.84	1.18	1.08	1.08
Candel Therapeutics, Inc. (CADL)vs ›	$740.03M	16.09	8.04	7.87	9.13
Achieve Life Sciences, Inc. (ACHV)vs ›	$715.02M	0.95	4.92	2.98	5.72
Design Therapeutics, Inc. (DSGN)vs ›	$756.55M	18.86	23.23	26.78	32.61
Attovia Therapeutics, Inc. (ATTO)vs ›	$764.21M	9.39	11.79	11.79	11.79
Cytek Biosciences, Inc. (CTKB)vs ›	$770.34M	3.86	4.81	5.95	7.14
Geron Corporation (GERN)vs ›	$773.03M	5.16	4.89	3.82	4.31
Lexicon Pharmaceuticals, Inc. (LXRX)vs ›	$777.34M	13.29	5.16	5.49	4.89

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

Avalo Therapeutics, Inc. (AVTX)

$719.62M

19.31

12.36

8.58

3.62

Anteris Technologies Global Corp. (AVR)vs ›

$716.11M

14.20

2.59

2.42

2.06

Collegium Pharmaceutical, Inc. (COLL)vs ›

$718.41M

0.84

1.18

1.08

Candel Therapeutics, Inc. (CADL)vs ›

$740.03M

16.09

8.04

7.87

9.13

Achieve Life Sciences, Inc. (ACHV)vs ›

$715.02M

0.95

4.92

2.98

5.72

Design Therapeutics, Inc. (DSGN)vs ›

$756.55M

18.86

23.23

26.78

32.61

Attovia Therapeutics, Inc. (ATTO)vs ›

$764.21M

9.39

11.79

Cytek Biosciences, Inc. (CTKB)vs ›

$770.34M

3.86

4.81

5.95

7.14

Geron Corporation (GERN)vs ›

$773.03M

5.16

4.89

3.82

4.31

Lexicon Pharmaceuticals, Inc. (LXRX)vs ›

$777.34M

13.29

5.16

5.49

4.89

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Avalo Therapeutics, Inc. (AVTX)?

The quick ratio (acid-test) for AVTX stock is 19.31.

Is Avalo Therapeutics, Inc.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 19.31 is 434% above its 5-year average of 3.62, near the high end of its 5-year range (0.33–22.61).

What is the TTM average quick ratio (acid-test) for Avalo Therapeutics, Inc. (AVTX)?

The TTM average quick ratio (acid-test) for AVTX stock is 12.36.

What is the 3Y average quick ratio (acid-test) for Avalo Therapeutics, Inc. (AVTX)?

The 3Y average quick ratio (acid-test) for AVTX stock is 8.58.

What is the 5Y average quick ratio (acid-test) for Avalo Therapeutics, Inc. (AVTX)?

The 5Y average quick ratio (acid-test) for AVTX stock is 3.62.

What is the 10Y average quick ratio (acid-test) for Avalo Therapeutics, Inc. (AVTX)?

The 10Y average quick ratio (acid-test) for AVTX stock is 1.63.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	19.31
2026-03-31	7.66
2025-12-31	8.14
2025-09-30	14.28
2025-06-30	12.44
2025-03-31	22.61
2024-12-31	19.96
2024-09-30	1.42
2024-06-30	0.99
2024-03-31	0.52
2023-12-31	1.82
2023-09-30	2.11
2023-06-30	0.33
2023-03-31	0.83
2022-12-31	0.74
2022-09-30	1.07
2022-06-30	0.97
2022-03-31	2.44
2021-12-31	3.11
2021-09-30	4.04
2021-06-30	2.18
2021-03-31	1.75
2020-12-31	1.71
2020-09-30	2.48
2020-06-30	3.44
2020-03-31	1.66
2019-12-31	1.46
2019-09-30	0.71
2019-06-30	0.71
2019-03-31	0.91
2018-12-31	0.79
2018-09-30	0.70
2018-06-30	0.54
2018-03-31	0.67
2017-12-31	0.93
2017-09-30	5.03
2017-06-30	3.57
2017-03-31	1.26
2016-12-31	1.31
2016-09-30	1.25
2016-06-30	1.98
2016-03-31	2.74
2015-12-31	3.70
2015-09-30	0.51
2015-06-30	1.08
2015-03-31	1.57
2014-12-31	2.44
2014-09-30	0.00
2014-06-30	0.00
2014-03-31	0.00
2013-12-31	1.35
2012-12-31	6.44

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

19.31

2026-03-31

7.66

2025-12-31

8.14

2025-09-30

14.28

2025-06-30

12.44

2025-03-31

22.61

2024-12-31

19.96

2024-09-30

1.42

2024-06-30

0.99

2024-03-31

0.52

2023-12-31

1.82

2023-09-30

2.11

2023-06-30

0.33

2023-03-31

0.83

2022-12-31

0.74

2022-09-30

1.07

2022-06-30

0.97

2022-03-31

2.44

2021-12-31

3.11

2021-09-30

4.04

2021-06-30

2.18

2021-03-31

1.75

2020-12-31

1.71

2020-09-30

2.48

2020-06-30

3.44

2020-03-31

1.66

2019-12-31

1.46

2019-09-30

0.71

2019-06-30

0.71

2019-03-31

0.91

2018-12-31

0.79

2018-09-30

0.70

2018-06-30

0.54

2018-03-31

0.67

2017-12-31

0.93

2017-09-30

5.03

2017-06-30

3.57

2017-03-31

1.26

2016-12-31

1.31

2016-09-30

1.25

2016-06-30

1.98

2016-03-31

2.74

2015-12-31

3.70

2015-09-30

0.51

2015-06-30

1.08

2015-03-31

1.57

2014-12-31

2.44

2014-09-30

0.00

2014-06-30

0.00

2014-03-31

0.00

2013-12-31

1.35

2012-12-31

6.44

Quick Ratio (Acid-Test): 19.31

AVTX Quick Ratio

AVTX Average Quick Ratio (Acid-Test) Chart

AVTX Current vs Average Quick Ratio (Acid-Test) Chart

AVTX Quick Ratio (Acid-Test) Metrics

AVTX Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

AVTX Quick Ratio (Acid-Test) History

Related Metrics